Cancers (Jan 2023)

The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages

  • Takakazu Nagahara,
  • Takaaki Sugihara,
  • Takuya Kihara,
  • Suguru Ikeda,
  • Yoshiki Hoshino,
  • Yukako Matsuki,
  • Takuki Sakaguchi,
  • Hiroki Kurumi,
  • Takumi Onoyama,
  • Tomoaki Takata,
  • Tomomitsu Matono,
  • Naoyuki Yamaguchi,
  • Hajime Isomoto

DOI
https://doi.org/10.3390/cancers15020390
Journal volume & issue
Vol. 15, no. 2
p. 390

Abstract

Read online

Alpha-fetoprotein (AFP) and des-gamma-carboxyprothrombin (DCP) are widely used as tumor markers to diagnose hepatocellular carcinoma (HCC). Some advanced HCCs demonstrate neither AFP nor DCP. This study investigated the characteristics and prognosis of AFP (p = 0.026). The median maximum tumor diameter was smaller in DNHC [3.2 (1.8–5.0) vs. 5.5 (3.5–9.0) cm, p = 0.001] and their median survival time was significantly better, even in higher-stage HCC [47.0 (24.0–84.0) vs. 19.0 (14.0–30.0) months, p = 0.027). DNHC in higher-BCLC stage HCC is independent of BCLC staging, characterized by a tumor diameter < 5 cm, and is treatable with a good prognosis.

Keywords